- $122.27m
- -$40.55m
- CNY922.20m
- 86
- 91
- 87
- 99
Annual cashflow statement for Ihuman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -37.5 | -37.1 | 110 | 181 | 98.6 |
| Depreciation | |||||
| Non-Cash Items | 81.3 | 16.8 | 20.3 | 9.53 | 2.75 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 176 | 52 | 47.5 | -30 | -56.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 223 | 38.2 | 188 | 172 | 58.5 |
| Capital Expenditures | -15.9 | -32.3 | -6.59 | -6.51 | -7.45 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.332 | -26.3 | 0 | -45.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -15.9 | -32 | -32.8 | -6.51 | -52.8 |
| Financing Cash Flow Items | -57.6 | 0.097 | 0 | — | -57.4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 572 | 0.41 | -6.96 | -9.45 | -102 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 757 | -6.32 | 195 | 164 | -90.5 |